InvestorsHub Logo
Followers 163
Posts 12880
Boards Moderated 1
Alias Born 01/26/2016

Re: exwannabe post# 665185

Friday, 01/19/2024 5:41:32 PM

Friday, January 19, 2024 5:41:32 PM

Post# of 699723
exwannabe,

The June 2019 article indicated 8 patients entered the trial with no measurable disease and 5 of these ended with no measurable disease from this group while 3 progressed. Also 1 patient out of 30 that actually had at least one vaccine given had a complete response with just over two year data available.
Bottom line is there is a long way to go with this tech and way behind L Phase 3 and their Poly ICLC adjuvant trials. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News